Topics
Low-grade gliomas | Overall management | Guidelines
Home > Publications > Topics > Low-grade gliomas > Overall management > Guidelines
Home > Publications > Topics > Collections > Guidelines
*Vaz-Salgado MÁ, García BC, Pérez IF,
Munárriz BJ, Domarco PS, González AH, Villar MV,
Caro RL, Delgado MLV, Sánchez JMS.
SEOM-GEINO
clinical guidelines for grade 2 gliomas (2023).
Clin
Transl Oncol. 2024 Apr 25. doi:
10.1007/s12094-024-03456-x. PMID:
38662171. Guidelines. ˍ
Ziu M, Halasz LM, Kumthekar PU, McGranahan TM, Lo SS, Olson JJ.
Congress of Neurological Surgeons
systematic review and evidence-based guidelines for the role of
chemotherapy in newly diagnosed WHO Grade II diffuse glioma in
adults: update.
J
Neurooncol. 2024 Nov 20. doi:
10.1007/s11060-024-04861-6. PMID:
39565459. Review; Guidelines˰
ˍ
Morrow K, Sloan A, Olson JJ, Ormond DR.
Congress
of Neurological Surgeons systematic review and evidence-based
guidelines on the management of recurrent diffuse low-grade
glioma: update.
J
Neurooncol. 2024 Oct 14. doi:
10.1007/s11060-024-04838-5. PMID:
39400661. Guidelines˰ ˍ
Mandelberg N, Hodges TR, Wang TJC, McGranahan T, Olson JJ,
Orringer DA.
Congress of Neurological
Surgeons systematic review and evidence based guideline on
neuropathology for WHO grade II diffuse glioma: update.
J
Neurooncol. 2025 Jan 2. doi:
10.1007/s11060-024-04898-7. PMID:
39747718. Guidelines˰ ˍ
Redjal N, Ziu M, Choi S, Ng PR, Nahed BV, Olson JJ.
Congress
of Neurological Surgeons systematic review and evidence-based
guidelines for the role of surgery in the management of patients
with diffuse low grade glioma: update.
J
Neurooncol. 2025 Jan 13. doi:
10.1007/s11060-024-04871-4. PMID:
39806106 Review; Guidelines˰
ˍ